Home›Diabetes & Endocrinology› In-utero GDM exposure is associated with higher offspring BMI and increased risk of obesity
In-utero GDM exposure is associated with higher offspring BMI and increased risk of obesityGestational diabetes in pregnancy linked to higher weight in children
Frontiers in MedicinePublished September 16, 2026DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Note that in-utero GDM exposure is associated with higher offspring BMI and a 2.09 odds ratio for obesity.
This meta-analysis evaluates the metabolic outcomes of offspring exposed to in-utero gestational diabetes mellitus (GDM) and the effects of active antenatal management, including diet, exercise, and pharmacotherapy. The analysis synthesizes both observational data and randomized controlled trials (RCTs) to determine the impact on offspring BMI, obesity risk, and glycemic markers.
Key findings indicate that in-utero GDM exposure is associated with a higher BMI (MD = 1.42 kg/m2; 95% CI: 0.94-1.89) and a significantly higher risk of overweight or obesity in adulthood (OR = 2.09; 95% CI: 1.25-3.50). Regarding active antenatal management, RCTs showed a non-significant trend towards lower HOMA-IR (MD = -0.30; 95% CI: -0.61 to 0.01) and a non-significant trend towards lower HbA1c (MD = -0.41%; 95% CI: -0.85 to 0.03). Other metrics, including fasting glucose, 2-hour OGTT glucose, total cholesterol, triglycerides, and HDL-C, showed no statistically significant combined effects.
The authors note significant limitations, including high variability in fasting glucose results (I^2 = 80.7%) and high heterogeneity in HbA1c results (I^2 = 99.1%). These factors, along with the need for extended longitudinal research, necessitate cautious interpretation of the findings. While in-utero GDM exposure is associated with metabolic risks in offspring, the impact of specific interventions remains uncertain due to high heterogeneity.
How this fits prior evidence
This meta-analysis extends the understanding of long-term metabolic risks following GDM. It builds upon findings that a 4-year lifestyle intervention cuts type 2 diabetes risk by 46% in post-GDM women and that postpartum dietary interventions improve BMI, weight, HOMA-IR, and HbA1c in women with a history of GDM. While those findings focus on maternal outcomes, this study identifies specific risks for offspring, including a 2.09 odds ratio for obesity, following in-utero GDM exposure.
When a mother develops gestational diabetes during pregnancy, it can create a lasting impact on the health of her child. New data shows that children born to these mothers are more likely to have a higher body mass index (BMI) and a higher risk of being overweight or obese as they grow into adulthood.
Researchers looked at how active management during pregnancy, such as diet and exercise, affects these outcomes. While some measurements like fasting glucose showed no clear combined impact, there were slight trends toward lower insulin resistance and lower HbA1c (a measure of average blood sugar) in children whose mothers received active care.
It is important to note that these findings come with some uncertainty. Because of high variability in the data, the results for blood sugar levels are not definitive. More long-term research is needed to confirm exactly how much prenatal care can change these long-term health risks for children.
What this means for you:
Children of mothers with gestational diabetes have a higher risk of being overweight, but active prenatal care shows some promise.
Common questions
Does gestational diabetes affect my child's weight?
Children of mothers with gestational diabetes are more likely to be overweight or obese in adulthood. Research shows these children often have a higher body mass index (BMI) compared to others.
Can managing gestational diabetes during pregnancy help my child?
Active management during pregnancy, including diet and exercise, showed a non-significant trend toward lower insulin resistance (HOMA-IR) and lower HbA1c levels in children. However, these results are not yet definitive.
How certain are these findings regarding blood sugar?
The results for fasting glucose and HbA1c levels showed high variability and inconsistency. Because of this, these specific findings should be interpreted with caution until more long-term research is available.
BackgroundGestational diabetes mellitus (GDM) affects 14–17% of pregnancies globally, imposing long-term public health burdens beyond pregnancy. Maternal hyperglycaemia increases offspring risk of metabolic disorders through epigenetic, hormonal and developmental programming. Growing evidence connects prenatal GDM exposure to childhood and adult metabolic diseases, yet the consistency and magnitude of these associations across different metabolic conditions remains unclear.MethodsWe systematically searched PubMed, Cochrane CENTRAL and Embase. Eligible studies included observational cohorts exploring associations between in-utero GDM exposure and offspring metabolic outcomes, and RCTs assessing maternal antenatal interventions. Bias risk was evaluated with Cochrane RoB 2 (for RCTs) and the Newcastle-Ottawa Scale (NOS) (for observational studies). Separate outcome-based pooled analyses were conducted, given the distinct clinical questions addressed by the two study designs. All meta-analyses used the random-effects inverse-variance model. Heterogeneity was assessed via I² and Cochran’s Q statistic, and Egger’s linear regression test was used to detect publication bias.ResultsSixteen studies (n=9 RCTs, n=7 observational cohorts) involving diverse populations across 11 countries were included. In observational cohorts, GDM-exposed offspring showed higher BMI (MD = 1.42 kg/m2, 95% CI: 0.94-1.89) and greater estimates for overweight/obesity in adulthood (OR = 2.09, 95% CI: 1.25–3.50, I² = 80.7%). The analysis of fasting glucose results displayed high variability (I² = 80.7%) yet produced no meaningful combined impact (MD = -0.016 mmol/L, 95% CI: -1.52 to 1.49). In RCTs, active antenatal GDM management was associated with a non-significant trend towards lower HOMA-IR (MD = -0.30, 95% CI: -0.61 to 0.01; I² = 68.2%) and HbA1c (MD = -0.41%, 95% CI: -0.85 to 0.03; I² = 99.1%) relative to usual care. There were no statistically significant combined effects found for 2-hour OGTT glucose levels total cholesterol levels triglyceride levels or HDL-C levels. Egger’s test revealed no significant publication bias for either glucose (t = 0.82, p = 0.43) or lipid outcomes (t = -0.08, p = 0.94).ConclusionIn-utero GDM exposure confers metabolic risks from childhood to adulthood; lifelong persistence requires verification via extended longitudinal research GDM interventions including diet, exercise and pharmacotherapy may lower offspring risk, although heterogeneity necessitates cautious interpretation.
